News
Australian researchers have demonstrated that the use of a new, less toxic drug combination after stem cell transplants for ...
Two allogeneic stem cell transplants, including a complex and highly challenging haploidentical (half-match) transplant were performed successfully at KIMS-Health Cancer Centre, marking a significant ...
All the patients in the phase 2 study received cyclophosphamide, tacrolimus and mycophenolate mofetil for graft-vs-host ...
Acute myeloid leukemia (AML ... The goal of consolidation therapy is to destroy any remaining leukemia cells. You may require a stem cell transplant for consolidation therapy.
Technical improvements have made transplantation safer. Standard chemotherapy cures a small minority of patients with acute myeloid leukemia. Postremission therapy is needed for cure. Cytogenetic ...
Debiopharm ( a privately-owned, Swiss-based biopharmaceutical company aiming to establish tomorrow’s standards of care to ...
Join Drs Tania Jain and Rachel Salit as they explore evolving definitions of remission, relapse monitoring, and ...
Trials enrolling patients with relapsed leukemia, lymphoma and brain cancers, respectively, report early data showing ...
Revumenib shows promise for high-risk patients with acute myeloid leukemia (AML) with specific genetic mutations, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results